Metabolic benefits of Ramadan intermittent fasting revealed: key lipid changes and inflammatory marker improvements

The lipidomic changes during Ramadan diurnal intermittent fasting (RIF) among obese individuals.

BioNTech exits PD-L1 development with Genmab as Q2 revenues drop – Pharmaceutical Technology

In a Q2 financial report, BioNTech announced that it would quit the joint development of acasunlimab with Genmab as it focuses on its antibody drug

August 5, 2024

Reunion Neuroscience Inc. to Participate in October Investor Conferences – Psychedelic Alpha

WILMINGTON, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions

November 1, 2023

Ad Insights | Data from BMS at AHA Bolster Evidence for BMS’ oHCM Treatment Option

For U.S. Healthcare Professionals Only For decades, treatment options for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), a heart disease characterized by the abnormal thickening

December 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.